RO7204239, RO7204239 Matching Placebo, Tirzepatide — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08-24 in 2mo
ESTIMATED |
READOUT
A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Phar
Phase 2 · Obesity, Overweight |
Hoffmann-La Roche | RO7204239, RO7204239 Matching Placebo, T |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|